
Group therapy helps cancer survivors reclaim life after treatment
A program developed by a McGill researcher to help cancer survivors cope with the fear their cancer will return is expanding across Canada.
The Fear of Recurrence Therapy (FORT) program offers evidence-based support to address what co-founder Christine Maheu calls one of the most overlooked aspects of recovery.

Navigating the dating world? It’s important to know what you want, researchers say
Single people who date without a clear understanding of what they are looking for in a relationship experience more loneliness and decreased life satisfaction, McGill researchers have found.

Exoplanet is observed shedding its atmosphere in real time
Using the James Webb Space Telescope (JWST), a team led by McGill researcher Vigneshwaran Krishnamurthy has observed a giant cloud of helium gas evaporating from a distant giant exoplanet called WASP-107b.

Scientists decode the full range of oat genomes, opening the door to more nutritious, climate-smart crops
Researchers have cracked one of agriculture’s most complicated genomes, revealing long-hidden DNA rearrangements that could help scientists breed oats that are more resilient, nutritious and sustainable.

McGill researchers develop stretchable, biodegradable battery using eco-friendly acids
Researchers with McGill’s Trottier Institute for Sustainability in Engineering and Design have developed a stretchable, eco-friendly battery suitable for use in wearable and implantable devices. The battery, which uses citric or lactic acid and gelatin to achieve flexibility and performance without relying on toxic materials, stands to reduce electronic waste.

Bringing environmental policymakers together to focus on the future sparks empathy for nature and later generations, McGill study finds
When environmental policymakers are invited to imagine the future together, they don’t just think differently, they feel differently, too.

New therapeutic strategies show promise against a hard-to-treat prostate cancer
A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.
McGill University researchers at the Rosalind and Morris Goodman Cancer Institute (GCI) identified a mechanism driving neuroendocrine prostate cancer, a rare and highly aggressive subtype for which there currently are no effective treatment options.
